SCHEMBL5197904

SCHEMBL5197904

NCCCc1ccc2c(=O)[nH]c(N(CCCc3ccc4c(=O)[nH]cnc4c3)C(=O)O)nc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IP6K1 Q92551 3/20 0.39
IP6K3 Q96PC2 1/20 0.39
IP6K2 Q9UHH9 1/20 0.39
ROCK2 O75116 1/20 0.38
DHFR P00374 3/20 0.36
FPGS Q05932 2/20 0.36
PARP1 P09874 2/20 0.36
ALDH1A1 P00352 2/20 0.36
CHEK1 O14757 1/20 0.36
PIM1 P11309 1/20 0.36
RPS6KA3 P51812 1/20 0.36
KDR P35968 2/20 0.33
EPHB4 P54760 2/20 0.33
TEK Q02763 2/20 0.33
EGFR P00533 1/20 0.33
PDGFRB P09619 1/20 0.33
KIT P10721 1/20 0.33
FGFR1 P11362 1/20 0.33
FLT1 P17948 1/20 0.33
USP2 O75604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4870787 0.80 PARP1 (0.53) IP6K1IP6K3IP6K2ROCK2DHFR
SCHEMBL5197913 0.74 IP6K1 (0.34) IP6K1IP6K3IP6K2ROCK2DHFR
SCHEMBL5097264 0.66 PARP1 (0.56) IP6K1IP6K3IP6K2ROCK2PARP1
SCHEMBL4066634 0.65 PARP1 (0.58) IP6K1IP6K3IP6K2ROCK2PARP1
SCHEMBL24617507 0.63 PARP1 (0.58) IP6K1IP6K3IP6K2ROCK2PARP1
SCHEMBL3796386 0.63 MAPT (0.42) IP6K1IP6K3IP6K2ALDH1A1KDM4E
SCHEMBL4875349 0.63 PARP1 (0.51) IP6K1IP6K3IP6K2ROCK2DHFR
SCHEMBL14003507 0.62 L3MBTL1 (0.44) IP6K1IP6K3IP6K2ROCK2PARP1
SCHEMBL29136065 0.61 PARP1 (0.53) IP6K1IP6K3IP6K2ROCK2PARP1
SCHEMBL27947189 0.61 PARP1 (0.55) IP6K1IP6K3IP6K2ROCK2PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814552-A2 COMPOUNDS FOR TREATING PROTEIN-KINASE MEDIATED DISORDERS Astex Therapeutics Limited (GB) 2007-08-08 EP disclosed
WO-2006051290-A2 COMPOUNDS FOR TREATING PROTEIN-KINASE MEDIATED DISORDERS ASTEX THERAPEUTICS LIMITED (GB) 2006-05-18 WO disclosed